GLP-1 Agonists for Obesity: Real-World Effectiveness & Results
How effective are GLP-1 medications in real-world obesity treatment?
Real-world data shows GLP-1 medications achieve 15-20% average body weight loss in patients with obesity. Approximately 85% of patients experience clinically significant weight loss, with results sustained through continued treatment.
Clinical Trial vs Real-World Results
Clinical trials show semaglutide achieves 15-17% weight loss and tirzepatide 20-22%. Real-world studies show slightly lower results (12-14% and 16-18% respectively) due to variable adherence and lifestyle support. Learn more about the science behind GLP-1 effectiveness.
Real-World Effectiveness by Medication
Semaglutide: 12-14% weight loss at 12 months, 68% achieve ≥10% loss. Tirzepatide: 16-18% weight loss at 12 months, 78% achieve ≥10% loss. Compare with tirzepatide vs semaglutide.
Long-Term Sustainability
Weight loss is maintained with continued treatment. After stopping, most patients regain 2/3 of lost weight within 12 months. Learn about preventing weight regain.
People Also Read
Ready to Start Your Weight Loss Journey?
Get started with physician-guided GLP-1 treatment from the comfort of your home.
Get Started TodayWritten by Dr. Sarah Mitchell
MD, Obesity Medicine
Our team of healthcare professionals specializes in weight management and metabolic health, providing evidence-based information to help you make informed decisions about your health journey.